Viewing Study NCT06533059


Ignite Creation Date: 2025-12-24 @ 2:35 PM
Ignite Modification Date: 2026-06-06 @ 6:43 PM
Study NCT ID: NCT06533059
Status: RECRUITING
Last Update Posted: 2025-11-26
First Post: 2024-07-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
Sponsor: Alterome Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Breast Cancer View
None Endometrial Cancer View
None Metastatic Cancer View
None Advanced Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AKT1 E17K View
None Breast cancer View
None Breast carcinoma View
None Breast neoplasm View
None ER positive breast View
None HR positive breast View
None Triple negative breast cancer View
None Gynecologic cancer View
None Gynecologic neoplasm View
None Gynecologic carcinoma View
None Endometrial cancer View
None Endometrial neoplasm View
None Endometrial carcinoma View
None Cervical cancer View
None Cervical neoplasm View
None Cervical carcinoma View
None Ovarian cancer View
None Ovarian carcinoma View
None Ovarian neoplasm View
None Fallopian cancer View
None Fallopian carcinoma View
None Fallopian neoplasm View
None Prostate cancer View
None Prostate carcinoma View
None Prostate neoplasm View
None Solid tumors View
None AKT mutation View
None Mutant AKT View
None AKT1 mutation View
None AKT mutant View
None AKT1E17K View